Tenon Medical, Inc. 8-K

What Happened

• Tenon Medical, Inc. announced it received a written notice from The Nasdaq Stock Market LLC dated May 21, 2026, notifying the company it is not in compliance with Nasdaq Listing Rule 5550(b)(1) due to insufficient stockholders' equity.
• In its Form 10-Q for the quarter ended March 31, 2026, the company reported stockholders' equity of $1,895,000, below the $2,500,000 minimum. The company also does not meet alternative Nasdaq standards for market value of listed securities or net income from continuing operations.

Key Details

• Nasdaq rule referenced: Listing Rule 5550(b)(1) (minimum stockholders' equity $2,500,000).
• Reported stockholders' equity: $1,895,000 (quarter ended March 31, 2026).
• Compliance deadline to submit a plan: 45 calendar days from the notice (until July 6, 2026); Nasdaq may grant an extension of up to 180 calendar days if a plan is accepted.
• The notice does not have any immediate effect on the listing or trading of the company's common stock; the company may appeal any delisting determination to a Nasdaq Hearings Panel.

Why It Matters

• This notice signals a regulatory risk: if Tenon Medical fails to have an accepted compliance plan or to regain the required equity within any granted extension, Nasdaq may begin delisting proceedings, which could affect the stock's listing status and liquidity.
• The company is evaluating options and intends to submit a plan to regain compliance, but it cautioned there is no assurance the plan will be accepted or that it will be able to regain compliance within the applicable periods.